| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Biophys J, April 2000, p. 2008-2021, Vol. 78, No. 4

and
*Institute of Biophysics, Academy of Sciences of the Czech
Republic, Brno, Czech Republic, and
Dipartimento
Farmaco-Chimico, University of Bari, I-70125 Bari, Italy
Modifications of natural DNA and synthetic
oligodeoxyribonucleotide duplexes in a cell-free medium by analogs of
antitumor cisplatin containing enantiomeric amine ligands, such as
cis-[PtCl2(RR-DAB)] and
cis-[PtCl2(SS-DAB)] (DAB = 2,3-diaminobutane), were studied by various methods of molecular
biophysics and biophysical chemistry. These methods include DNA binding
studies by pulse polarography and atomic absorption spectrophotometry,
mapping of DNA adducts using transcription assay, interstrand
cross-linking assay using gel electrophoresis under denaturing
conditions, differential scanning calorimetry, chemical probing, and
bending and unwinding studies of the duplexes containing single,
site-specific cross-link. The major differences resulting from the
modification of DNA by the two enantiomers are the thermodynamical
destabilization and conformational distortions induced in DNA by the
1,2-d(GpG) intrastrand cross-link. It has been suggested that these
differences are associated with a different biological activity of the
two enantiomers observed previously. In addition, the results of the
present work are also consistent with the view that formation of
hydrogen bonds between the carbonyl oxygen of the guanine residues and
the "quasi equatorial" hydrogen of the cis amine in
the 1,2-d(GpG) intrastrand cross-link plays an important role in
determining the character of the distortion induced in DNA by this lesion.
Biophys J, April 2000, p. 2008-2021, Vol. 78, No. 4
© 2000 by the Biophysical Society 0006-3495/00/04/2008/14 $2.00
This article has been cited by other articles:
![]() |
J. Malina, O. Novakova, M. Vojtiskova, G. Natile, and V. Brabec Conformation of DNA GG Intrastrand Cross-Link of Antitumor Oxaliplatin and Its Enantiomeric Analog Biophys. J., December 1, 2007; 93(11): 3950 - 3962. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Delalande, J. Malina, V. Brabec, and J. Kozelka Chiral Differentiation of DNA Adducts Formed by Enantiomeric Analogues of Antitumor Cisplatin Is Sequence-Dependent Biophys. J., June 1, 2005; 88(6): 4159 - 4169. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kasparkova, O. Novakova, V. Marini, Y. Najajreh, D. Gibson, J.-M. Perez, and V. Brabec Activation of Trans Geometry in Bifunctional Mononuclear Platinum Complexes by a Piperidine Ligand: MECHANISTIC STUDIES ON ANTITUMOR ACTION J. Biol. Chem., November 28, 2003; 278(48): 47516 - 47525. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Novakova, J. Kasparkova, J. Malina, G. Natile, and V. Brabec DNA-protein cross-linking by trans-[PtCl2(E-iminoether)2]. A concept for activation of the trans geometry in platinum antitumor complexes Nucleic Acids Res., November 15, 2003; 31(22): 6450 - 6460. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Hofr, N. Farrell, and V. Brabec Thermodynamic properties of duplex DNA containing a site-specific d(GpG) intrastrand crosslink formed by an antitumor dinuclear platinum complex Nucleic Acids Res., May 15, 2001; 29(10): 2034 - 2040. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Hofr and V. Brabec Thermal and Thermodynamic Properties of Duplex DNA Containing Site-specific Interstrand Cross-link of Antitumor Cisplatin or Its Clinically Ineffective Trans Isomer J. Biol. Chem., March 23, 2001; 276(13): 9655 - 9661. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |